-
The Rise of Alpha-Ketoglutarate (AKG) in the Anti-Aging Landscape
Aug , 07 2024
The Rise of Alpha-Ketoglutarate (AKG) in the Anti-Aging Landscape realm of scientific discoveries that hold the promise of extending human lifespan and enhancing overall health, the role of mitochondr...
read more
-
Synthetic Biology Revolutionizing Vitamin Production: Towards Sustainable Development
Aug , 06 2024
Synthetic biology is increasingly becoming a green and efficient alternative in the production of vitamins. Microbial fermentation synthesis, as a key technological approach, avoids the use of toxic c...
read more
-
Water-Soluble Coenzyme Q10: Chinese Innovations in Advancing Formulations
Aug , 05 2024
Coenzyme Q10 (CoQ10) is a natural lipid compound found widely in the human body, known for its role in enhancing energy metabolism in myocardial cells. Beyond this, it boasts significant antioxidant, ...
read more
-
Biological Enzyme Breakthrough: Revolutionizing Hormonal Drug Production
Aug , 05 2024
Recently, the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences achieved a significant breakthrough in biological enzyme catalysis technology for treating hormonal drugs...
read more
-
Semaglutide in China: Advancements in Production, Quality, and Competitive Pricing
Jul , 25 2024
Semaglutide (CAS No: 910463-68-2) belongs to the class of GLP-1 receptor agonists and is used both as an antidiabetic for treating type 2 diabetes and as an anti-obesity medication for long-term weigh...
read more
-
EU's Approval of Novel HMOs Ingredients Including 2'-FL, 3-FL, and 6'-SL for Food Applications
Jul , 09 2024
In recent years, the European Union (EU) has paid particular attention to the category of Novel Foods during its approval process, with a focus on Human Milk Oligosaccharides (HMOs). HMOs, as crucial ...
read more
-
Two types of Linkers Utilized in Antibody Drug Conjugates (ADCs): cleavable linkers and non-cleavable linkers.
Jun , 25 2024
In antibody drug conjugates (ADCs), two types of linkers are typically used: cleavable linkers and non-cleavable linkers. Cleavable linkers release the cytotoxic payload near the desired location with...
read more
-
The key factors driving the ADC linker and antibody conjugation technologies market
Jun , 25 2024
The key factors driving the ADC linker and antibody conjugation technologies market can be summarized as follows: Growing Prevalence of Oncological Disorders: Cancer and other oncological disorders ha...
read more
-
Advancing ADC Linker and Antibody Conjugation Technology for the Development of Homogenous Antibody Drug Conjugates
Jun , 25 2024
Rising interest in ADC linker and antibody conjugation technology for the development of homogenous antibody drug conjugates (ADCs) is driven by the need for targeted cancer therapies with improved sa...
read more
-
The Evolving Global Antibody Drug Conjugate (ADC) Technology Market: Growth Prospects, Challenges, and Advancements.
Jun , 25 2024
The rapid growth of the global ADC (Antibody Drug Conjugate) technology market indicates a significant increase in interest and investment in this area of biotherapeutics. ADCs have been recognized as...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
